Possessing decades of experience as both a physician and an educator, Mark Holterman, MD, serves as a professor of medicine at the University of Illinois College of Medicine. In addition to his work educating students, Dr. Mark Holterman is a longtime supporter of the American Diabetes Association.
Continuous glucose monitoring (CGM) systems provide people with diabetes real-time feedback about changes in their blood sugar levels. This helps them decide whether or not to eat different things or integrate some exercise into their daily routines. Even though these devices offer significant benefits to patients, they are not used as much as they could be, because a lack of standardized guidelines exist on how they should be prescribed. That’s why the American Diabetes Association has partnered with the European Association for the Study of Diabetes to issue a joint statement called “Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations.”
The new statement provides recommendations on marketing, clinical data reporting, and regulatory guidance, among other items. It can be found in the December 2017 edition of Diabetes Care and is based on a comprehensive examination of 50-plus scientific articles about CGMs.